Bayesian Capital Management’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-17,000
| Closed | -$125K | – | 776 |
|
|
2025
Q1 | $125K | Buy |
+17,000
| New | +$125K | 0.02% | 529 |
|
|
2024
Q2 | – | Sell |
-10,304
| Closed | -$93.8K | – | 989 |
|
|
2024
Q1 | $93.8K | Buy |
+10,304
| New | +$93.8K | 0.01% | 718 |
|
|
2023
Q3 | – | Sell |
-37,400
| Closed | -$193K | – | 898 |
|
|
2023
Q2 | $193K | Buy |
+37,400
| New | +$193K | 0.02% | 644 |
|
|
2022
Q3 | – | Sell |
-16,200
| Closed | -$65K | – | 929 |
|
|
2022
Q2 | $65K | Buy |
16,200
+2,200
| +16% | +$8.83K | 0.01% | 708 |
|
|
2022
Q1 | $69K | Buy |
+14,000
| New | +$69K | 0.01% | 717 |
|